Amlodipine And Olmesartan Medoxomil recalls
Amlodipine And Olmesartan Medoxomil products have been recalled 6 times, most recently on 29 Jul 2026. The recalling company is usually Ascend Laboratories. The most common reason is potency & assay.
Total recalls6since 2018
Last 12 months2reported
Class I00% of total
Ongoing3latest 29 Jul 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 5 83%Class III 1 17%
Why amlodipine and olmesartan medoxomil is recalled
Companies
Product types
By year
Ongoing amlodipine and olmesartan medoxomil recalls
3 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg recalledAmlodipine And Olmesartan Medoxomil | Ascend Laboratories | Potency & Assay | Nationwide |
| Drug | CLASS II | Amlodipine and Olmesartan Medoxomil Tablets, 5mg/40mg recalledAmlodipine And Olmesartan Medoxomil | Ascend Laboratories | Potency & Assay | Nationwide |
| Drug | CLASS II | Amlodipine and Olmesartan Medoxomil Tablets, 5 mg/ 40 mg recalledAmlodipine And Olmesartan Medoxomil | Ascend Laboratories | Potency & Assay | Nationwide |
All amlodipine and olmesartan medoxomil recalls, newest first
6 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg recalledAmlodipine And Olmesartan Medoxomil | Ascend Laboratories | Potency & Assay | Nationwide |
| Drug | CLASS II | Amlodipine and Olmesartan Medoxomil Tablets, 5mg/40mg recalledAmlodipine And Olmesartan Medoxomil | Ascend Laboratories | Potency & Assay | Nationwide |
| Drug | CLASS II | Amlodipine and Olmesartan Medoxomil Tablets, 5 mg/ 40 mg recalledAmlodipine And Olmesartan Medoxomil | Ascend Laboratories | Potency & Assay | Nationwide |
| Drug | CLASS II | Amlodipine and Olmesartan Medoxomil Tablets, 10 mg /20 mg recalledAmlodipine And Olmesartan Medoxomil | Macleods Pharma Usa | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Amlodipine and Olmesartan Medoxomil Tablets 10 mg/20 mg recalledAmlodipine And Olmesartan Medoxomil | Cardinal Health | Manufacturing (CGMP) Deviations | FL, GA, SC |
| Drug | CLASS III | Amlodipine and Olmesartan Medoxomil Tablets, 5 mg/40 mg recalledAmlodipine And Olmesartan Medoxomil | Aurobindo Pharma USA | Other | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.